Treatments using venlafaxine
AssigneeWyeth
InventorsRichard L. Rudolph, Albert T. Derivan
Life of this patent
Estimating the term…
Loading patent…
AssigneeWyeth
InventorsRichard L. Rudolph, Albert T. Derivan
Estimating the term…
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase dysphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: 1 in which A is a moiety of the formula 2 where the dotted line represents optional unsaturation; R1 is hydrogen or alkyl; R2 is alkyl; R4 is hydrogen, alkyl, formyl, or alkanol; R5 and R6 are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R7 is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.
A method of treating bulimia nervosa in a mammal, comprising administering to the mammal an effective amount of a compound of the formula:
A method of treating bulimia nervosa in a mammal, comprising administering to the mammal a pharmaceutical composition comprising an effective amount of a compound of the formula:
Dependencies are inferred from the claim text.